GIVLAARI

Serial Number 88237293
Registration 6164815
700

Registration Progress

Application Filed
Dec 20, 2018
Under Examination
Jun 25, 2019
Approved for Publication
Apr 30, 2019
Published for Opposition
Apr 30, 2019
Registered
Sep 29, 2020

Basic Information

Serial Number
88237293
Registration Number
6164815
Filing Date
December 20, 2018
Registration Date
September 29, 2020
Published for Opposition
April 30, 2019
Drawing Code
3

Status Summary

Current Status
Active
Status Code
700
Status Date
Sep 29, 2020
Registration
Registered
Classes
005

Rights Holder

Alnylam Pharmaceuticals, Inc.

03
Address
300 Third Street
Cambridge, MA 02142

Ownership History

Alnylam Pharmaceuticals, Inc.

Original Applicant
03
Cambridge, MA

Alnylam Pharmaceuticals, Inc.

Owner at Publication
03
Cambridge, MA

Alnylam Pharmaceuticals, Inc.

Original Registrant
03
Cambridge, MA

Legal Representation

Attorney
Timothy H. Hiebert

USPTO Deadlines

Next Renewal Deadline
448 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2020-09-29)
Due Date
September 29, 2026
Grace Period Ends
March 29, 2027
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

27 events
Date Code Type Description
Sep 29, 2020 R.PR A REGISTERED-PRINCIPAL REGISTER
Aug 28, 2020 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Aug 27, 2020 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Aug 24, 2020 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 24, 2020 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 20, 2020 ALIE A ASSIGNED TO LIE
Aug 1, 2020 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 14, 2020 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 14, 2020 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 14, 2020 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 29, 2020 DOCK D ASSIGNED TO EXAMINER
Feb 5, 2020 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 5, 2020 GNRT F NON-FINAL ACTION E-MAILED
Feb 5, 2020 CNRT W SU - NON-FINAL ACTION - WRITTEN
Dec 18, 2019 SUPC I STATEMENT OF USE PROCESSING COMPLETE
Dec 18, 2019 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL
Dec 11, 2019 IUAF S USE AMENDMENT FILED
Dec 11, 2019 EISU I TEAS STATEMENT OF USE RECEIVED
Jun 25, 2019 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Apr 30, 2019 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 30, 2019 PUBO A PUBLISHED FOR OPPOSITION
Apr 10, 2019 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 18, 2019 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 15, 2019 DOCK D ASSIGNED TO EXAMINER
Jan 15, 2019 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED
Jan 12, 2019 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 24, 2018 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of porphyria
First Use Anywhere: Dec 10, 2019
First Use in Commerce: Dec 10, 2019

Additional Information

Design Mark
The mark consists of the word "GIVLAARI" and a design of four curved, nested bands.
Color Claim
Color is not claimed as a feature of the mark.
Translation
The wording "GIVLAARI" has no meaning in a foreign language.

Classification

International Classes
005